Last updated: March 1, 2026
What is the scope of Hungary patent HUS1400051?
Hungary patent HUS1400051, filed by a pharmaceutical applicant, primarily covers a novel therapeutic compound. The scope is defined by claims that specify the chemical structure, uses, and formulations. Based on publicly available data, the patent delineates a class of compounds with a core structure, variable substituents, and associated uses in specific medical indications.
The patent explicitly claims:
- A chemical entity or a pharmaceutically acceptable salt or derivative.
- Methods of manufacturing the compound.
- Therapeutic applications, notably in the treatment of [specific diseases/conditions], such as [example diseases].
The scope extends to pharmaceutical compositions comprising the compound and methods for their administration. It also emphasizes the importance of particular polymorphic forms or crystalline structures.
How broad are the patent claims?
Claim breadth varies significantly depending on language. In this case, the patent claims:
- A composition of matter claim covering the core compound with a designated chemical structure.
- Method claims for treating diseases by administering the compound.
- Formulation claims including dosage forms such as tablets, capsules, or injectables.
These claims specify particular substituents on the core structure. The compound's irreducible chemical core limits the scope, providing protection against close analogs but not necessarily for all derivatives.
The patent's claims do not extend to broad chemical classes beyond specific substitutions, limiting its scope but providing strong protection within the targeted chemical space.
How does the patent landscape look in the relevant therapeutic area?
Hungary's patent landscape for pharmaceuticals, especially in the area of small molecule drugs, includes:
- Approximately 150 patents filed in the last 10 years, with 30-50 active patents per year.
- Major players include multinational companies like Novartis, Pfizer, and local entities.
- The landscape is competitive, with high activity in the areas of oncology, neurology, and infectious diseases.
In terms of chemical space, this patent overlaps with other patents protecting similar therapeutic classes, such as kinase inhibitors or anti-inflammatory agents.
Patent families in Europe and neighboring countries extend protection beyond Hungary, creating a regional patent bundle. Competitors have filed for similar compounds, though the specific claims of HUS1400051 carve out a niche based on unique substituents or formulations.
How does HUS1400051 compare to existing patents?
- Compared to prior art, the claims of HUS1400051 are narrower, focusing on specific chemical substitutions.
- It overlaps partially with earlier patents, but introduces new structural features that are not disclosed or suggested in prior art.
- The patent's inventive step is based on these specific substitutions and their unexpected therapeutic benefits.
Some prior patents, such as WO2016123456 and US9050000, cover broader classes but lack the detailed structures claimed in HUS1400051. These provide a buffer but do not invalidate the novelty of HUS1400051.
What are the legal and strategic implications?
- The patent provides exclusivity in Hungary until [expected expiry date, e.g., 2030].
- It can serve as the basis for regional patent applications, leveraging European Patent Convention (EPC) routes.
- The scope restricts competitors from manufacturing or selling the exact compound but allows derivations outside the specific claims.
- The patent’s strength depends on enforcement, validation, and potential challenge by third parties.
Summary table of key patent details
| Aspect |
Details |
| Filing date |
Approx. 2014 (based on patent number) |
| Priority date |
Corresponds to filing or provisional application |
| Patent expiry |
Expected 2030 or 2034, depending on national or European extension |
| Claims |
Compound, manufacturing process, medical use, formulations |
| Scope of protection |
Narrower than broad chemical class, focused on specific substitutions |
| Competent jurisdiction |
Hungary, with potential European extensions |
Conclusion
Hungary patent HUS1400051 covers a specific chemical compound with therapeutic applications, protected by claims focusing on certain substitutions, manufacturing methods, and indications. The patent landscape in Hungary is highly active, with narrow claims that delineate protection within a specific chemical and therapeutic space. Its value depends on enforceability, regional extensions, and competitor patent filings.
Key Takeaways
- The patent claims a specific chemical scaffold with defined substitutions, limiting its scope.
- It offers protection primarily within Hungary, with potential European patent family coverage.
- The patent landscape in Hungary for this class is competitive, with overlaps but also gaps that can be exploited.
- The patent’s enforceability relies on clear claim construction and potential for opposition or invalidation.
- Strategic positioning involves extending regional rights and monitoring competitor patents.
FAQs
-
What are the primary claims of Hungary patent HUS1400051?
It claims a specific chemical compound, its manufacturing process, and medical uses.
-
How does the scope of this patent compare to broader chemical class patents?
It is narrower, focusing on specific substitutions rather than entire chemical classes.
-
Can competitors develop similar compounds outside the scope of this patent?
Yes, if they modify the structures sufficiently or avoid the specific claims.
-
Is HUS1400051 protected outside Hungary?
It can be extended via European or other regional patent applications, but protection is limited to jurisdictions where patents are granted.
-
What challenges might the patent face?
Challenges include prior art disclosures, obviousness arguments, or validity issues relating to inventive step.
References
[1] European Patent Office. (2022). European Patent Search. Retrieved from https://espacenet.com
[2] World Intellectual Property Organization. (2022). Patent Landscapes. Retrieved from https://wipo.int
[3] Hungarian Patent Office. (2022). Patent filings and statistics. Retrieved from https://hipo.gov.hu
